LOW vs ORGO · P/E 18, rev $49.03B vs rev $81.0M
Lowe's Companies Inc (LOW) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the LOW and ORGO stock pages for the full models.
Not investment advice.